Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01695980 · ClinicalTrials.gov registry record · NA

Laryngeal Mask Airway in Pediatric Adenotonsillectomy

A NA study, sponsored by Eastern Virginia Medical School.

Completed
Registry status
NA
Development phase
81
Enrollment target

NCT01695980: Completed NA study, sponsored by Eastern Virginia Medical School.

NCT01695980 is a NA study that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 81 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01695980, a NA study, has completed, sponsored by Eastern Virginia Medical School.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target

Study Summary

The study will compare how often the tubing kinks when a LMA (laryngeal mask airway) with modified retractor is used compared to use of an endotracheal tube (ETT) and non modified retractor is used.

Primary Outcome

Mouth gag equipment is used for the LMA and the ETT. A modified tongue depressor is used with the LMA and a non-modified tongue depressor is used with the ETT. Data will be collected in regards to the rate of kinking/obstruction of the tubing with each type of equipment to determine which option is the best for use in adenotonsillectomy.

Interventions

  • PROCEDURE ETT with non modified retractor
  • OTHER LMA with modified retractor

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2012-08
Est. Completion 2022-03-29
Phase NA
Eastern Virginia Medical School

36 total trials

What the finished NCT01695980 record still lists

NCT01695980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which ETT with non modified retractor is the first listed.

NCT01695980 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01695980 about?

NCT01695980 is a clinical study titled "Laryngeal Mask Airway in Pediatric Adenotonsillectomy". The study will compare how often the tubing kinks when a LMA (laryngeal mask airway) with modified retractor is used compared to use of an endotracheal tube (ETT) and non modified retractor is used.

What is the current status of trial NCT01695980?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2012-08. Estimated completion is 2022-03-29.

What interventions are being tested in trial NCT01695980?

The interventions under investigation include: ETT with non modified retractor (PROCEDURE), LMA with modified retractor (OTHER).

Who is sponsoring clinical trial NCT01695980?

This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01695980's enrollment target sits among peer trials

81 992nd of 2000 higher than 1,007 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04966481 · 81 participants · Phase 3

    Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

  • NCT05109429 · 81 participants · NA

    Developing a Clinical Outcome Assessment for Opioid Craving

  • NCT05112601 · 81 participants · Phase 2

    Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • NCT05305911 · 81 participants · Phase 2

    Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01695980, the US trial registry maintained by the National Library of Medicine. NCT01695980 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.